Strides Pharma Science Limited (NSE: STAR)

Market Cap	125.04B
Revenue (ttm)	42.09B
Net Income (ttm)	67.01M
Shares Out	91.96M
EPS (ttm)	0.73
PE Ratio	n/a
Forward PE	26.69
Dividend	2.50 (0.18%)
Ex-Dividend Date	Sep 9, 2024

Volume	329,047
Open	1,352.00
Previous Close	1,344.85
Day's Range	1,344.85 - 1,395.00
52-Week Range	452.50 - 1,395.00
Beta	0.82
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 28, 2024

About Strides Pharma Science

Strides Pharma Science Limited develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, India, and internationally. It operates through two segments, Pharmaceutical and Biopharmaceutical. The company offers pharma generics in various forms, such as tablets, hard and soft gelatin capsules, sachets, and liquids, as well as nasal spray, gels, powders, solids, ointments, and creams. It also develops branded generics products for the treatment of chronic therapies, including women’s health, central...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1990
• Employees: 2,850
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: STAR

Financial Performance

In 2023, STAR's revenue was 40.51 billion, an increase of 9.83% compared to the previous year's 36.88 billion. Losses were -706.14 million, -65.15% less than in 2022.